{"organizations": [], "uuid": "9a9d3f51e3ac4d03b3588b88119f9b3e01fcd77e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180206.html", "section_title": "Archive News &amp; Video for Tuesday, 06 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-usana-health-sciences-reports-q4-l/brief-usana-health-sciences-reports-q4-loss-per-share-0-24-idUSASB0C4CJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Usana Health Sciences Reports Q4 Loss Per Share $0.24", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.022, "site_type": "news", "published": "2018-02-07T05:24:00.000+02:00", "replies_count": 0, "uuid": "9a9d3f51e3ac4d03b3588b88119f9b3e01fcd77e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-usana-health-sciences-reports-q4-l/brief-usana-health-sciences-reports-q4-loss-per-share-0-24-idUSASB0C4CJ", "ord_in_thread": 0, "title": "BRIEF-Usana Health Sciences Reports Q4 Loss Per Share $0.24", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "china", "sentiment": "none"}], "organizations": [{"name": "usana", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-usana health sciences reports", "sentiment": "negative"}, {"name": "usana health sciences inc", "sentiment": "negative"}, {"name": "nd", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Usana Health Sciences Inc:\n* USANA HEALTH SCIENCES REPORTS RECORD FOURTH QUARTER AND FULL-YEAR 2017 NET SALES\n* Q4 ADJUSTED EARNINGS PER SHARE $1.11 * Q4 LOSS PER SHARE $0.24 * Q4 SALES ROSE 8 PERCENT TO $273.1 MILLION * USANA HEALTH - NET LOSS IN QUARTER ATTRIBUTABLE TO ONE-TIME, CHARGE OF $30.1 MILLION, OR $1.24 PER SHARE, RELATED TO U.S. TAX REFORM\n* SEES 2018 ‍CONSOLIDATED NET SALES BETWEEN $1.11 AND $1.16 BILLION​\n* USANA HEALTH - COSTS RELATED TO CHINA AND CO‘S INTERNAL INVESTIGATION INTO CHINA OPERATIONS NEGATIVELY IMPACTED Q4 EARNINGS PER SHARE BY $0.11\n* SEES 2018 CONSOLIDATED NET SALES BETWEEN $1.11 AND $1.16 BILLION\n* SEES 2018 EARNINGS PER SHARE $4.05 AND $4.45 * USANA - AUDIT COMMITTEE OF BOARD HAS ASSUMED DIRECT RESPONSIBILITY FOR REVIEWING MATTERS RELATED TO INTERNAL INVESTIGATION OF CHINA OPERATIONS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T05:24:00.000+02:00", "crawled": "2018-02-07T21:58:39.024+02:00", "highlightTitle": ""}